VRTX

Vertex Pharmaceuticals (VRTX), classified under the Health Care sector, has drawn disclosed trading activity from six members of Congress across 21 total transactions in the public record, spanning from December 2022 through June 2026. The balance of activity leans toward accumulation, with 13 purchases against 8 sales, and the most-active disclosing members include Ro Khanna, Byron Donalds, Jefferson Shreve, and Julia Letlow; no bipartisan co-trading clusters are recorded for this security. The disclosure record does not surface any co-trading clusters that cross party lines, and the volume of congressional interest across six members is relatively modest for a name in its sector. Separately, 12 executive-branch officials have disclosed 15 transactions in the same security in independent public filings, with the closest congressional and executive purchases falling 26 days apart — a sequence observable in the public record.